Volume 18, Number 6—June 2012
Molecular Epidemiology of Geographically Dispersed Vibrio cholerae, Kenya, January 2009–May 2010
Numerous outbreaks of cholera have occurred in Kenya since 1971. To more fully understand the epidemiology of cholera in Kenya, we analyzed the genetic relationships among 170 Vibrio cholerae O1 isolates at 5 loci containing variable tandem repeats. The isolates were collected during January 2009–May 2010 from various geographic areas throughout the country. The isolates grouped genetically into 5 clonal complexes, each comprising a series of genotypes that differed by an allelic change at a single locus. No obvious correlation between the geographic locations of the isolates and their genotypes was observed. Nevertheless, geographic differentiation of the clonal complexes occurred. Our analyses showed that multiple genetic lineages of V. cholerae were simultaneously infecting persons in Kenya. This finding is consistent with the simultaneous emergence of multiple distinct genetic lineages of V. cholerae from endemic environmental reservoirs rather than recent introduction and spread by travelers.
Cholera, caused by the bacterium Vibrio cholerae and characterized by a profuse watery diarrhea, has been a serious public health problem since the first recorded pandemic in 1817. In 2009, the World Health Organization (WHO) reported just over 220,000 cholera cases and nearly 5,000 cholera-related deaths in 45 countries; however, these estimates are thought to be substantially underestimated because many countries where cholera is endemic do not report cases. During the past 20 years, the highest reported incidence shifted from the Americas to Africa. Africa accounted for 98% of reported cholera cases and 99% of reported cholera-related deaths during 2009.
Kenya has had numerous outbreaks of cholera since the first case was detected there in 1971 (1); 15 discrete outbreaks of cholera were documented during 1971–2010 (2–6). In western Kenya during January–April 2008, a cholera outbreak affected 10 administrative districts in Nyanza Province (adjacent to Lake Victoria), resulting in 790 cases and 53 deaths (case-fatality rate 6.7%) (6). The peak of the outbreak (January 2008) occurred after the December 2007 presidential election in Kenya, which had disputed results that triggered periods of protest, violence, public transportation disruption, and work stoppages throughout the country.
After an outbreak subsides in the lake region of Kenya, it has been suggested that V. cholerae becomes extinct in that locale but that isolated pockets of disease linger elsewhere in the region, and when the climate becomes favorable, V. cholerae reemerges and spreads from the refuge (7). The most recent outbreak occurred during January 2009–May 2010; cholera was detected in at least 52 districts throughout the country, and a total of 11,769 cases and 274 deaths (case-fatality rate ≈2.3%) were reported to the Kenya Ministry of Public Health and Sanitation. The regularity of these outbreaks indicates that V. cholerae might be frequently spread by travelers or that it is endemic to the area.
Published epidemiologic studies used the best methods available at the time to differentiate isolates of V. cholerae in Kenya. For example, several investigations (8) used pulsed-field gel electrophoresis (PFGE) to characterize the genetic relatedness of the isolates responsible for cholera outbreaks. These studies found that all of the isolates were closely related, as would be expected if there was a spread from a single source. However, PFGE (9,10) discriminates poorly among serotype O1 and O139 V. cholerae strains. Multilocus-variable tandem repeat analysis (MLVA), however, has been reported to be useful in differentiating V. cholerae O1 strains in various rural communities and within households (11–14). To more fully understand the epidemiology of cholera in Kenya, we used MLVA to characterize the genetic relatedness of V. cholerae strains isolated from persons throughout the country.
We identified all districts in Kenya that reported cases of cholera during January 2009–May 2010. The Division of Disease Surveillance and Response, Ministry of Public Health and Sanitation, Kenya, provided a list of cases that met a clinical case definition for cholera. For the purpose of this study, we defined cholera as sudden onset of >3 episodes of watery diarrhea in a 24-h period in a person >2 years of age (compared with 5 years of age in the WHO definition) or <2 years of age if a clinician suspected cholera and V. cholerae was isolated from a stool specimen (corresponds with the WHO confirmed case definition, http://www.who.int/cholera/technical/prevention/control/en/index1.html). We used records from the provincial headquarters of the affected provinces and districts to update the list. After compiling a complete and up-to-date national list, we divided the country into 5 geographic regions, according to local climate conditions: the coastal region, the arid and semi-arid region, the lake region, the lower eastern region, and the highland region (Figure 1). We estimated the population of these regions by adding the population of districts within each region (data provided by the National Bureau of Statistics, Kenya 2009 Population and Housing Census Highlights, www.knbs.or.ke/Census%20Results/KNBS%20Brochure.pdf).
Isolation of V. cholerae Strains in Kenya
Stool or rectal swab specimens were obtained from 222 persons with suspected cases of cholera who met the clinical case definition during the 2009–2010 cholera outbreak. The specimens were transferred onto Cary-Blair medium and transported (at 2°–8°C) to the Kenya National Public Health Laboratory Services, Nairobi, within 48 hours after collection. They were then cultured (37°C, 8 h) in alkaline peptone water and subcultured (37°C, 18–24 h) on thiosulfate–citrate–bile salts–sucrose agar (HiMedia Laboratories Ltd., Mumbai, India). After the specimens were subcultured, putative V. cholerae isolates were examined for sucrose fermentation. Suspicious colonies were subcultured (37°C, 18–24 h) again on Mueller-Hinton agar (Scharlau Chemie, Barcelona, Spain). All isolates were tested for the presence of oxidase, and they were serotyped with a polyvalent O1 antiserum and with monospecific Inaba and Ogawa antisera (Denka Seiken, Tokyo, Japan). All confirmed V. cholerae isolates were stored at −80°C in trypticase soy broth (Scharlau Chemie) supplemented with 20% (vol/vol) glycerol.
Of the 222 stool specimens collected, 173 (78%) yielded V. cholera isolates; they were stored at −80°C until use. Of these 173 frozen isolates, 170 were revived by streaking onto Luria-Bertani agar and grown overnight at 37°C. Single, well-isolated colonies were selected to be grown in Luria-Bertani broth overnight at 37°C. We isolated V. cholerae DNA from the broth cultures by using PrepMan Ultra (ABI, Foster City, CA, USA) according to the manufacturer’s instructions. We used PCR and primers as described (13) to amplify 5 loci containing variable length tandem repeats. Agarose gel electrophoresis was used to confirm the presence of amplified products.
The fluorescent-labeled products were separated and detected by using a model 3730xl Automatic Sequencer (ABI); internal lane standards (Liz600; ABI) and the GeneScan program (ABI) were used to determine produce sizes. Genotypes were determined by using published formulas to calculate the number of repeats from the length of each allele and to order the alleles at the 5 loci. The 5 loci, in order, are VC0147, VC0436–7 (intergenic), VC1650, VCA0171, and VCA0283; thus, the genotype 9,4,6,19,11 indicates that the isolate has alleles of 9, 4, 6, 19, and 11 repeats at the 5 loci, respectively. These standard loci will be in the global V. cholerae MLVA database, which is currently being developed (contact email@example.com). Relatedness of the strains was assessed by using eBURSTv3 (http://eburst.mlst.net). Genetically related genotypes were defined as those possessing identical alleles at 4 of the 5 loci. The mismatch amplification mutation PCR was used to screen for the cholera toxin–encoding gene, as described (15).
During January 2009–May 2010, 11,769 cases of cholera were reported to the Division of Disease Surveillance and Response, Kenyan Ministry of Public Health and Sanitation. Demographic and geographic information was obtained for 10,497 of the case-patients, of whom 246 (2.3%) died and 173 (1.65%) had laboratory-confirmed cholera. Case-patients who met the clinical case definition were reported from 52 (35%) of the country’s 149 districts and from all 5 geographic regions (Table 1). The age range for case-patients was 1–76 years (overall mean 23 years, SD ± 18 years). The attack rate ranged from 0.02% in the lake and highland regions to 10-fold higher (0.2%) in the arid and semi-arid region. Case fatality rates ranged from 0.7% in the coastal region to 4.0% in the arid and semi-arid region (Table 1).
Cases of cholera were reported almost every day during January 2009–May 2010, and the number of cases reported during any 1 day ranged from 1 to 160 for the entire country. The first reported case was from the lake region (reported on January 2, 2009), and index cases appeared during the next 2 months in each of the other 4 regions. In the highland (including Nairobi), arid and semi-arid North, lower eastern, and coastal regions, the index cases were reported on February 22, February 26, March 12, and May 28, respectively. Every index case heralded the start of an apparent unified outbreak in the respective regions (Technical Appendix [PDF - 217 KB - 1 page]), during which time, the number of cases progressively increased. For example, in the lake, arid and semi-arid, highland, and lower eastern regions, the first outbreak peak occurred on January 20, April 7, May 5, and November 4, respectively. After the initial flush of cases in each region, the number of cases per week decreased to few or none; however, additional peaks, with numerous cases per week, would occur later.
Classical ctxB, Biotype and Serotype
Consistent with the possible spread of V. cholerae across the country, each of the 170 isolates was biotype El Tor and carried the classical ctxB allele, as measured by mismatch amplification mutation PCR. In contrast, 84% of the isolates were serotype Inaba, and the other 16% were serotype Ogawa.
Multilocus-Variable Tandem Repeat Analysis
MLVA of the V. cholerae O1 isolates revealed extensive genetic diversity. To determine whether the strains were genetically related, we genotyped all 170 isolates at 5 loci containing variable numbers of tandem repeats. All loci exhibited substantial variation; for example, VC0147, VC436–7 (intergenic), VC1650, VCA0171, and VCA0283 had 9, 4, 6, 21, and 24 alleles, respectively. When each isolate was assigned a genotype (on the basis of and in order of the number of repeat units at each locus), 106 genotypes were detected among the 170 isolates. eBURSTv3 analysis to determine the genetic relatedness of the genotypes revealed 5 clonal complexes, each comprising a series of genotypes that differed by an allelic change at a single locus. In addition, we detected 19 singleton genotypes that were unrelated to any other genotype; that is, they differed at >2 loci from all other genotypes. The arid and semi-arid region yielded 42% (8 isolates) of these singletons; the coast, highland, and lake regions contributed 26% (5 isolates), 21% (4 isolates), and 11% (2 isolates), respectively. No singletons were detected in the lower eastern region.
The 3 largest clonal complexes (designated 1, 2, and 3) occurred throughout most of the country. Clonal complex 1 contained 52 different genotypes among 89 isolates (Figure 2, panel A), and it was observed in every region (Table 2). The most common genotype, identified as the founder genotype (defined as the genotype that differed from the largest number of other genotypes at only 1 locus), was observed in 22 isolates collected from informal settlements around Nairobi. The founder genotype radiated into 12 other genotypes, and 7 of those differentiated further. No distinct correlation between the geographic locations and genotype of the isolates was detected.
Clonal complex 2, which contained 20 different genotypes among 33 isolates (Figure 2, panel B), was detected in the Rift Valley (in the western part of the arid and semi-arid region) and in the coastal, lower eastern, and highland (primarily represented by informal settlements around Nairobi) regions. Clonal complex 3, which contained 11 genotypes among 23 isolates (Figure 2, panel C) was detected in the coastal, lake, and highland regions and in the Rift Valley (arid and semi-arid region).
Some geographic differentiation of the clonal complexes appears to have occurred (Table 2). The 3 large clonal complexes were distributed in a statistically significant (p<0.0002, by 3 × 4 χ2 test), nonrandom manner across the arid and semi-arid, coastal, highland, and lower eastern regions (the lake region had too few isolates to be tested). This significant difference can be attributed to the finding that clonal complex 2 was the most common complex in the arid and semi-arid region, and clonal complexes 1 and 3 were the most common complexes in the highland region. These findings are consistent with our observation that clonal complexes 4 and 5 were each seen in only 1 region, but they are very small groups. Clonal complex 4 isolates were found during various months; however, the complex 5 isolates were found only during February 2009, which was during the beginning of the outbreak in Moyale, an isolated village on the border with Ethiopia.
Figure 3 shows the temporal distribution of the 5 genetically distinct clonal complexes and the singletons for 4 regions; no temporal separation of the various clonal complexes is apparent. Isolates collected in February 2009 from the highland region and arid part of the arid and semi-arid region belong to distinct clonal complexes, 1 and 5, respectively; however, isolates collected in March 2009 from the same 2 regions all belong to clonal complex 1. Substantial variation was observed early in the outbreak: 2 or 3 clonal complexes are represented in the first 7 isolates genotyped from each region. In the highlands region, every 3-month period in which isolates were found has >2 distinct genotypes (Figure 3, panel A). In the coastal region, every month >1 isolate assayed has >2 genotypes (Figure 3, panel B). In the arid and semi-arid region, April and May 2009, when 4 isolates were assayed, are the only 2 consecutive months with a single genotype (Figure 3, panel C). Even in the lower eastern region, where only 13 isolates were assayed, multiple genotypes were observed in the 2 months in which >1 isolate was found (Figure 3, panel D).
The results of our genetic analyses suggest that the most recent outbreak of cholera in Kenya (beginning in January 2009) represented several distinct genetic lineages of V. cholerae that emerged simultaneously, perhaps facilitated by environmental and behavioral factors around the country. Thus, these data suggest that these outbreaks likely resulted from endemic foci rather than from recent introduction and spread by travelers.
In contrast, previous outbreaks of cholera in Kenya have been attributed to the spread of V. cholerae by travelers. Outbreaks in the 1990s and in 2005 were attributed to a clone carried by travelers to Nairobi; from there, it spread to other locations in the country (4). Likewise, the well-publicized 2010 cholera outbreak in Haiti also appears to have resulted from the introduction of V. cholerae by travelers (16). In addition, there have been repeated introductions of V. cholerae into previously disease-free locations by travelers from Southeast Asia and other areas where cholera is endemic (17). On a smaller scale, V. cholerae is thought to persist around the African Great Lakes Region because, although it becomes extinct in areas, it is still present in other localities and can spread when weather conditions are favorable (7).
Genetic uniformity is expected when V. cholerae is spread from a single source. This expectation conflicts with the observation that isolates with Inaba and Ogawa serotypes occurred during the outbreak. However, the expectation is consistent with the genetic evidence that all isolates had the El Tor biotype and identical (by Tenover’s criteria) (18) PFGE patterns (J.O. Oundo, et al. unpub. data). The nearly identical (single band) differences in the PFGE patterns are consistent with whole genome sequencing results showing that the toxigenic El Tor lineage of O1 V. cholerae has few large (several kilobytes) insertions or deletions (19) and few nucleotide changes (17). Large insertions or deletions or nucleotide changes in restrictions sites are the mutations that produce altered PFGE patterns; their absence in the El Tor lineage is consistent with the minimal number of PFGE patterns.
All V. cholerae strains that we studied from the 2009–2010 outbreak in Kenya had the classical ctxB allele, which is consistent with a clonal origin. The earlier population of V. cholerae is presumed to have contained only the El Tor allele because the classical ctxB allele was not detected before 1989 in isolates with the El Tor background (20). Thus, the presence of the classical allele in all isolates from the 2009–2010 outbreak most likely represents a rapid shift in allele frequency. Such a shift occurred in O1 V. cholerae in Kolkata, India, when allele frequency changed from 100% El Tor in 1989 to 100% classical ctxB in 1995 (20). It is of critical clinical importance that, the classical ctxB allele, when found in the background of an El Tor strain, has been associated with a more severe form of cholera than that caused by a strain with the El Tor ctxB allele (21,22).
Our MLVA genotyping results for 170 V. cholerae isolates from the 2009–2010 outbreak in Kenya showed extensive genetic diversity: we found 5 clonal complexes and 19 singleton genotypes. In contrast, studies using PFGE found genetic uniformity among V. cholerae isolates from 1994 to 2010 (5,8) (J.O. Oundo, et al. unpub. data). These differences may be explained by the finding that MLVA is superior to PFGE for discriminating between isolates of V. cholerae O1 (11–13).
An alternative explanation for the substantial variation observed among V. cholerae isolates from Kenya is that their tandem repeat loci may result from a rapid accumulation of mutations. However, 3 findings have documented the relative stability of those loci. First, an analysis of the variation occurring during a month-long serial passage revealed that the 3 large chromosomal loci (the primary determinants of membership in the various clonal complexes) were largely stable (13). Second, the clonal complexes remained distinct during 3 consecutive years in Bangladesh (13), longer than the 17 months of the 2009–2010 outbreak in Kenya. Third, all isolates from the cholera outbreak that began in October 2010 in Haiti belonged to a single clonal complex (16). These observations and the co-occurrence of distinct clonal complexes are consistent with the idea that there were multiple simultaneous outbreaks of cholera in Kenya.
Diverse MLVA genotyping results are found in countries where V. cholerae is endemic. In India, 6 clonal complexes were detected in V. cholerae O1 isolates (23), and in Bangladesh, 7 clonal complexes were detected (12). Consistent with these findings, we detected 5 clonal complexes in isolates from Kenya. The genetic diversity is also consistent with data from single-nucleotide polymorphism analyses that showed the several distinct waves of immigration of V. cholerae into Kenya (17), if the descendants of these immigrants settled and survived. The presence of multiple distinct lineages across the country supports the notion that there have been multiple introductions of V. cholerae and that over time these strains spread countrywide. The multiplicity of clonal complexes is in stark contrast to the apparent uniformity of the ctxB allele. An earlier study demonstrated that the ctxB alleles, as part of a mobile genetic element, were found in distinct locations in different MLVA clonal complexes (14).
The timing of the observed diversity is consistent with multiple separate outbreaks and not with the spread of disease by travelers. In February 2009, isolates from highland region, including Nairobi, belonged to clonal complex 1 and might have spread from the lake region. However, isolates from Moyale in the arid and semi-arid region belonged to clonal complex 5, and the time between the initial observations in the southern part of the country and the far north was too short for the isolates to have evolved into a new clonal complex. In addition, the far north is a region where travel is difficult and people from south seldom travel. Thus, these 2 outbreaks appear to be temporally, geographically, and genetically separate. As stated, the mutations necessary for 1 clonal complex to evolve into another are not expected to occur in a few months. Thus, during the 2009–2010 outbreak, the occurrence of isolates from a second complex in the highland region (clonal complex 3) and the arid and semi-arid region (clonal complex 2) cannot be explained by evolutionary changes. In addition, no source was found from which travelers could have introduced these V. cholerae strains. A similar argument can be made for clonal complex 4 isolates and for each of the singletons scattered across the country. That is, the time to their appearance was too short to represent an evolutionary change, and there was no source from which a traveler spread the genetically distinct isolates. Thus, our analyses led to the conclusion that V. cholerae is endemic in Kenya. The extensive genetic variation among the isolates exposes a limitation in our sampling scheme. Our sampling should have included many more isolates from each region and each time period. The observed genetic differences permit distinguishing between regions, but the small number of samples limits what can be inferred about what is happening within a region.
Kenya has experienced multiple major outbreaks of cholera, and different regions of the country have reported different attack rates. During the 2009–2010 outbreak, all of the isolates collected contained the classical ctxB allele. Despite this genetic uniformity, our MLVA results showed that the isolates had extensive genetic variation within and between geographic locations. The genetic relatedness studies we performed showed that 5 clonal complexes and 106 different genotypes were part of the outbreak; thus, V. cholerae had several genetic lineages. Our data are consistent with V. cholerae isolates being endemic throughout Kenya.
This project was supported in part by the University of Maryland Clinical Research Unit of the Food and Waterborne Diseases Integrated Research Network and a subcontract from an RO1 to R. Bradley Sack (grants N01-AI-40014325 and RO-1A1039129, National Institute of Allergy and Infectious Diseases).
Mr Mohamed is a field coordinator for the Field Epidemiology Laboratory Training Program at Jomo Kenyatta University of Agriculture and Technology, Nairobi, where he is also pursuing his PhD. His research interests focus on cholera in Kenya and Tanzania.
- Scrascia M, Maimone F, Mohamud KA, Materu SF, Grimont F, Grimont PA, Clonal relationship among Vibrio cholerae O1 El Tor strains causing the largest cholera epidemic in Kenya in the late 1990s. J Clin Microbiol. 2006;44:3401–4.
- Tauxe RV, Mintz ED, Quick RE. Epidemic cholera in the new world: translating field epidemiology into new prevention strategies. Emerg Infect Dis. 1995;1:141–6.
- Shapiro RL, Otieno MR, Adcock PM, Phillips-Howard PA, Hawley WA, Kumar L, Transmission of epidemic Vibrio cholerae O1 in rural western Kenya associated with drinking water from Lake Victoria: an environmental reservoir for cholera? Am J Trop Med Hyg. 1999;60:271–6.
- Scrascia M, Pugliese N, Maimone F, Mohamud KA, Ali IA, Grimont PA, Cholera in Ethiopia in the 1990 s: epidemiologic patterns, clonal analysis, and antimicrobial resistance. Int J Med Microbiol. 2009;299:367–72.
- Mugoya I, Kariuki S, Galgalo T, Njuguna C, Omollo J, Njoroge J, Rapid spread of Vibrio cholerae O1 throughout Kenya, 2005. Am J Trop Med Hyg. 2008;78:527–33.
- Shikanga OT, Mutonga D, Abade M, Amwayi S, Ope M, Limo H, High mortality in a cholera outbreak in western Kenya after post-election violence in 2008. Am J Trop Med Hyg. 2009;81:1085–90.
- Nkoko DB, Giraudoux P, Plisnier PD, Tinda AM, Piarroux M, Sudre B, Dynamics of cholera outbreaks in great lakes region of Africa, 1978–2008. Emerg Infect Dis. 2011;17:2026–34.
- Kiiru JN, Saidi SM, Goddeeris BM, Wamae NC, Butaye P, Kariuki SM. Molecular characterisation of Vibrio cholerae O1 strains carrying an SXT/R391-like element from cholera outbreaks in Kenya: 1994–2007. BMC Microbiol. 2009;9:275.
- Kurazono H, Yamasaki S, Ratchtrachenchai O, Nair GB, Takeda Y. Analysis of Vibrio cholerae O139 Bengal isolated from different geographical areas using macrorestriction DNA analysis. Microbiol Immunol. 1996;40:303–5.
- Basu A, Garg P, Datta S, Chakraborty S, Bhattacharya T, Khan A, Vibrio cholerae O139 in Calcutta, 1992–1998: incidence, antibiograms, and genotypes. Emerg Infect Dis. 2000;6:139–47.
- Danin-Poleg Y, Cohen LA, Gancz H, Broza YY, Goldshmidt H, Malul E, Vibrio cholerae strain typing and phylogeny study based on simple sequence repeats. J Clin Microbiol. 2007;45:736–46.
- Stine OC, Alam M, Tang L, Nair GB, Siddique AK, Faruque SM, Seasonal cholera from multiple small outbreaks, rural Bangladesh. Emerg Infect Dis. 2008;14:831–3.
- Kendall EA, Chowdhury F, Begum Y, Khan AI, Li S, Thierer JH, Relatedness of Vibrio cholerae O1/O139 isolates from patients and their household contacts, determined by multilocus variable-number tandem-repeat analysis. J Bacteriol. 2010;192:4367–76.
- Choi SY, Lee JH, Jeon YS, Lee HR, Kim EJ, Ansaruzzaman M, Multilocus variable-number tandem repeat analysis of Vibrio cholerae O1 El Tor strains harbouring classical toxin B. J Med Microbiol. 2010;59:763–9.
- Morita M, Ohnishi M, Arakawa E, Bhuiyan NA, Nusrin S, Alam M, Development and validation of a mismatch amplification mutation PCR assay to monitor the dissemination of an emerging variant of Vibrio cholerae O1 biotype El Tor. Microbiol Immunol. 2008;52:314–7.
- Ali A, Chen Y, Johnson JA, Redden E, Mayette Y, Rashid MH, Recent clonal origin of cholera in Haiti. Emerg Infect Dis. 2011;17:699–701.
- Mutreja A, Kim DW, Thomson NR, Connor TR, Lee JH, Kariuki S, Evidence for several waves of global transmission in the seventh cholera pandemic. Nature. 2011;477:462–5.
- Tenover FC, Arbeit RD, Goering RV. How to select and interpret molecular strain typing methods for epidemiological studies of bacterial infections: a review for healthcare epidemiologists. Molecular Typing Working Group of the Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol. 1997;18:426–39.
- Chun J, Grim CJ, Hasan NA, Lee JH, Choi SY, Haley BJ, Comparative genomics reveals mechanism for short-term and long-term clonal transitions in pandemic Vibrio cholerae. Proc Natl Acad Sci U S A. 2009;106:15442–7.
- Raychoudhuri A, Patra T, Ghosh K, Ramamurthy T, Nandy RK, Takeda Y, Classical ctxB in Vibrio cholerae O1, Kolkata, India. Emerg Infect Dis. 2009;15:131–2.
- Siddique AK, Nair GB, Alam M, Sack DA, Huq A, Nizam A, El Tor cholera with severe disease: a new threat to Asia and beyond. Epidemiol Infect. 2010;138:347–52.
- Nair GB, Qadri F, Holmgren J, Svennerholm AM, Safa A, Bhuiyan NA, Cholera due to altered El Tor strains of Vibrio cholerae O1 in Bangladesh. J Clin Microbiol. 2006;44:4211–3.
- Ghosh R, Nair GB, Tang L, Morris JG, Sharma NC, Ballal M, Epidemiological study of Vibrio cholerae using variable number of tandem repeats. FEMS Microbiol Lett. 2008;288:196–201.
Suggested citation for this article: Mohamed AA, Oundo J, Kariuki SM, Boga HI, Sharif SK, Akhwale W, et al. Molecular epidemiology of geographically dispersed Vibrio cholerae O1, Kenya, January 2009–May 2010. Emerg Infect Dis [serial on the Internet]. 2012 Jun (date cited). http://dx.doi.org/10.3201/eid1806.111774
Comments to the Authors
Comments to the EID Editors
Please contact the EID Editors via our Contact Form.
- Page created: May 10, 2012
- Page last updated: May 10, 2012
- Page last reviewed: May 10, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)